Summary

Results from the Efficacy and Safety of GTR in Comparison to Copaxone trial [GATE; NCT01489254] show that GTR, a generic form of glatiramer acetate (GA), is as effective and safe as the brand-name drug for the treatment of patients with relapsing-remitting multiple sclerosis (RRMS).